Bioorganic & Medicinal Chemistry ( IF 3.3 ) Pub Date : 2020-06-30 , DOI: 10.1016/j.bmc.2020.115604 Daniel B Goetz 1 , Michelle L Varney 2 , David F Wiemer 3 , Sarah A Holstein 2
|
Geranylgeranyl diphosphate synthase (GGDPS) inhibitors are of potential therapeutic interest as a consequence of their activity against the bone marrow cancer multiple myeloma. A series of bisphosphonates linked to an isoprenoid tail through an amide linkage has been prepared and tested for the ability to inhibit GGDPS in enzyme and cell-based assays. The amides were designed as analogues to triazole-based GGDPS inhibitors. Several of the new compounds show GGDPS inhibitory activity in both enzyme and cell assays, with potency dependent on chain length and olefin stereochemistry.
中文翻译：
酰胺作为基于三唑的香叶基香叶基二磷酸合酶抑制剂的生物电子等排体。
香叶基香叶基二磷酸合酶 (GGDPS) 抑制剂因其对骨髓癌多发性骨髓瘤的活性而具有潜在的治疗意义。已经制备了一系列通过酰胺键连接到类异戊二烯尾部的双膦酸盐，并在基于酶和细胞的测定中测试了抑制 GGDPS 的能力。酰胺被设计为类似于基于三唑的 GGDPS 抑制剂。几种新化合物在酶和细胞测定中均显示出 GGDPS 抑制活性，其效力取决于链长和烯烃立体化学。
京公网安备 11010802027423号